https://wfneurology.org/activities/news-events/neurology-news News feed from World Federation of Neurology This issue features many reports from our member societies around the globe detailing their activities for July's World Brain Day 2025 and its theme, "Brain Health for All Ages." You can read about WBD celebrations throughout Sri Lanka, South Africa, India, and Pakistan. We analyzed data from 279 individuals from the PADUA-CESNE cohort: 120 with Parkinson's disease (PD), 88 with Alzheimer's disease (AD), 16 with frontotemporal dementia (FTD), 11 with multiple system atrophy (MSA), 14 with progressive supranuclear palsy (PSP), and 30 cognitively unimpaired controls. The WFN September 2025 issue of the OPEN ACCESS journal eNeurologicalSci Vol. 40 is now available online. In 2022, the World Health Organization (WHO) released the Intersectoral Global Action Plan (IGAP) on epilepsy and other neurologic disorders. One of its main goals is improving access to care for people living with epilepsy (PLWE), particularly in low- and middle-income countries where about 80% of these patients live. Prestroke disability, measured by the modified Rankin Scale (mRS), is routinely used in older (≥65 years) patients to predict stroke outcomes. Frailty, a common geriatric syndrome, is also associated with poor health outcomes but is rarely assessed in older stroke patients.  In the bustling lecture halls of Zambia’s leading medical school, the University of Zambia School of Medicine (UNZA-SOM), a quiet revolution has been underway. The subject: Neurology — a discipline infamous for sparking “neurophobia” (or fear of neurology) among students around the globe. World Federation of Neurology warmly congratulates Dr. Chandrashekhar Meshram on his appointment by the Ministry of Health and Family Welfare, Government of India, as President of the All India Institute of Medical Sciences (AIIMS ⧉), Bibinagar, Hyderabad For this Neuro-ID update, we review recent developments in neuroinfectious diseases across the globe, including potential complications of Oropouche virus, new discoveries regarding the pathophysiology of MIS-C in COVID-19, and reports on Chandipura virus. Neurofilament light chain (NfL) conventionally reflects disability worsening in multiple sclerosis (MS), but does not necessarily imply MS-specific mechanisms and could be affected by biological or pathological aging, including Alzheimer disease (AD) pathology. We aim to evaluate clinical correlates of plasma NfL (pNfL) in elderly patients with MS, and its associations with AD plasma biomarkers. Alzheimer's disease (AD) is a progressive neurodegenerative disorder for which there is currently no cure, and its incidence is on the rise. Early detection is essential for timely intervention and slowing the progression of the disease. While the brain structures of healthy aging individuals change gradually, the aging trajectories in AD patients deviate significantly...